Spain Biotechnology & Medical Research

Oryzon Genomics SA (ORY)

Track

Track

Oryzon Genomics SA has recorded no insider trading activity within the past three months. The most recent transaction occurred on September 21, 2022, involving a sale of shares by a business development director. Historical data indicates previous divestments by key personnel, though no significant market movements have been reported recently regarding these specific equity changes.
Ticker: ORY Exchange: MCE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oryzon Genomics SA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
EMILI TORRELL CORTADA DIRECTOR DE DESARROLLO DE NEGOCIO Officer
Transaction date
Sale
Price
315.38
Quantity 66,783
Value €4,654,662
Tamara Maes Consejera dominical Director
Transaction date
Sale
Price
164.72
Quantity 1,499
Value €3,608,293
Tamara Maes Consejera Director
Transaction date
Sale
Price
14.70
Quantity 66,631
Value €3,298,466
Carlos Manuel Buesa Arjol Consejero Director
Transaction date
Sale
Price
3.72
Quantity 250,000
Value €930,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-27 2022-09-21 S Sale
EMILI TORRELL CORTADA

DIRECTOR DE DESARROLLO DE NEGOCIO

Officer
66,783
315.38
€4,654,662 		66,783 315.38 €4,654,662
2021-02-27 2021-02-26 S Sale
Tamara Maes

Consejera dominical

Director
1,499
164.72
€3,608,293 		1,499 164.72 €3,608,293
2020-12-30 2020-12-29 S Sale
Tamara Maes

Consejera

Director
66,631
14.70
€3,298,466 		66,631 14.70 €3,298,466
2020-12-30 2020-12-29 S Sale
Carlos Manuel Buesa Arjol

Consejero

Director
250,000
3.72
€930,000 		250,000 3.72 €930,000
Explore more

More insider trading research around Oryzon Genomics SA

More insider trades in Spain
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe